J. Maurizis

发表

SYNTHESIS OF NONIONIC GLYCOSIDIC SURFACTANTS DERIVED FROM TRIS(HYDROXYMETHYL) AMINOMETHANE. PRELIMINARY ASSESSMENT

A. Polidori, B. Pucci, A. Pavia, 1994 .

Differential effects of n-3 and n-6 polyunsaturated fatty acids on BRCA1 and BRCA2 gene expression in breast cell lines

Y. Bignon, P. Fustier, D. BERNARD-GALLON, 2002, British Journal of Nutrition.

Synthesis of new cotelomers derived from tris(hydroxymethyl) aminomethane bearing arabinofuranosylcytosine moieties. Preliminary results on their in vitro and in vivo antitumoral activities

B. Pucci, J. Lacombe, J. Maurizis, 1998 .

Quantification by affinity perfusion chromatography of phosphorylated BRCAl and BRCA2 proteins from tumor cells after lycopene treatment.

Y. Bignon, L. Le Corre, N. Chalabi, 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

Determination of BRCA2 oncosuppressor protein expression in human mammary cells by affinity perfusion high-performance chromatography.

Y. Bignon, D. BERNARD-GALLON, J. Maurizis, 2001, Journal of biochemical and biophysical methods.

Influence of genistein and daidzein on Brca1 protein levels in human breast cell lines.

Y. Bignon, D. BERNARD-GALLON, J. Maurizis, 1998, Journal of the National Cancer Institute.

IgG purification to measure the level of an iodinated thyroglobulin peptide, the 3,5,3′,5′ tetraiodo-l-tyrosyl-l-tyrosine in human serum

J. Michelot, J. Maurizis, D. Bernard, 1985, Experientia.

Pharmacokinetic study of cystemustine, administered on a weekly schedule in cancer patients.

J. Madelmont, J. Armand, C. Marchenay, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

The effects of lycopene on the proliferation of human breast cells and BRCA1 and BRCA2 gene expression.

Y. Bignon, L. Le Corre, N. Chalabi, 2004, European journal of cancer.

Presence of BRCA1 and BRCA2 proteins in human milk fat globules after delivery.

Y. Bignon, P. Fustier, L. Le Corre, 2002, Biochimica et biophysica acta.

Isolation and purification of HLA-DR antigens from tumour cells by affinity chromatography and chromatofocusing

P. Chollet, J. Chassagne, J. Maurizis, 1998 .

Detection of reverse transcriptase activity in human breast tumors.

P. Chollet, J. Maurizis, R. Plagne, 1988, Anticancer research.

Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines.

Y. Bignon, D. BERNARD-GALLON, C. Hızel, 1999, Biochemical and biophysical research communications.

Effects of Monounsaturated and Polyunsaturated Fatty Acids (v-3 and v-6) on Brca1 Protein Expression in Breast Cell Lines

Y. Bignon, D. BERNARD-GALLON, P. Bougnoux, 1998 .

Effect of epidermal growth factor in HLA class I and class II transcription and protein expression in human breast adenocarcinoma cell lines.

Y. Bignon, P. Chollet, F. Courjal, 1992, British Journal of Cancer.

Ovarian hormones, antiestrogen and pregnancy effects on the expression of class II histocompatibility antigens by N-nitroso-N-methylurea-induced rat mammary carcinomas.

P. Chollet, J. Chassagne, J. Maurizis, 1989, Immunopharmacology.

Design, synthesis and preliminary biological evaluations of novel amphiphilic drug carriers.

B. Pucci, Christiane Contino-Pépin, Sandrine Périno, 2006, Bioorganic & medicinal chemistry letters.

Analysis of secreted protease inhibitors after water stress in potato tubers.

J. Madelmont, E. Débiton, G. Ledoigt, 2006, International journal of biological macromolecules.

Synthesis and surface-active properties of glycosyl carbamates and thioureas.

B. Pucci, J. Lacombe, J. Maurizis, 1999, Carbohydrate research.

Disposition and metabolism of a novel antineoplastic agent, 4-tert-butyl-[3-(2-chloroethyl)ureido]benzene, in mice.

A. Veyre, J. Madelmont, R. Gaudreault, 1998, Drug metabolism and disposition: the biological fate of chemicals.

Synthesis of 4-tert-butyl-3-(2-chloro-[-2-14C]ethyl)ureido benzene

A. Veyre, J. Madelmont, R. C.-Gaudreault, 1997 .

New quaternary ammonium oxicam derivatives targeted toward cartilage: synthesis, pharmacokinetic studies, and antiinflammatory potency.

J. Madelmont, I. Giraud, J. Maurizis, 1999, Journal of medicinal chemistry.

Cytotoxic effects of kinetin riboside on mouse, human and plant tumour cells.

J. Madelmont, G. Ledoigt, J. Maurizis, 2004, International journal of biological macromolecules.

Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrest.

C. Delage, A. Simon, A. Chulia, 1996, Cancer letters.

Metabolism of a new radioprotector; S-acetyl-N-glycyl cysteamine. I. Absorption, distribution and excretion metabolites in mice bearing EMT6 tumours.

A. Veyre, J. Madelmont, J. Imbach, 1988, Xenobiotica; the fate of foreign compounds in biological systems.

Methionine dependency and cancer treatment.

J. Madelmont, M. Vasson, X. Durando, 2003, Cancer treatment reviews.

Synthesis and in vitro evaluation of quaternary ammonium derivatives of chlorambucil and melphalan, anticancer drugs designed for the chemotherapy of chondrosarcoma.

J. Madelmont, I. Giraud, J. Maurizis, 2002, Journal of medicinal chemistry.

Comparison of Class II HLA antigen expression in normal and carcinomatous human breast cells.

P. Chollet, J. Chassagne, J. Maurizis, 1985, Cancer research.

Main excretion metabolites of 7-methoxy-2-nitronaphtho[2,1-b]furan (R 7000) in rats.

J. Madelmont, D. Dauzonne, J. Maurizis, 1986, Xenobiotica; the fate of foreign compounds in biological systems.

Separation of iodinated compounds of L-tyrosyl-L-tyrosine from iodothyronines by reversed-phase high-performance liquid chromatography

J. Michelot, J. Maurizis, G. Meyniel, 1982 .

Enhancement by O6-benzyl-N-acetylguanosine derivatives of chloroethylnitrosourea antitumor action in chloroethylnitrosourea-resistant human malignant melanocytes.

A. Veyre, J. Madelmont, J. Sauzieres, 1994, The Journal of pharmacology and experimental therapeutics.

A New O6-Alkylguanine-DNA Alkyltransferase Inhibitor Associated with a Nitrosourea (Cystemustine) Validates a Strategy of Melanoma-Targeted Therapy in Murine B16 and Human-Resistant M4Beu Melanoma Xenograft Models

J. Papon, J. Madelmont, A. Croisy, 2008, Journal of Pharmacology and Experimental Therapeutics.

Joint scintigraphy in rabbits with 99mtc-N-[3-(triethylammonio)propyl]-15ane-N5, a new radiodiagnostic agent for articular cartilage imaging.

A. Veyre, M. D. De Latour, J. Madelmont, 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Disposition in rats of N-pyridinium-propyl-cyclam, N-triethylammonium-propyl-cyclam, and N-[Triethylammonium]-3-propyl-[15]ane-N5, potential cartilage imaging agents.

J. Madelmont, J. Maurizis, M. Rapp, 2000, Drug metabolism and disposition: the biological fate of chemicals.

In vitro binding of oxime acetylcholinesterase reactivators to proteoglycans synthesized by cultured chondrocytes and fibroblasts.

A. Veyre, J. Madelmont, J. Maurizis, 1992, Biochemical pharmacology.

Disposition and metabolism of 2,6-dimethylbenzamide N-(5-methyl-3-isoxazolyl) (D2916) in male and female rats.

A. Veyre, J. Madelmont, J. Maurizis, 1997, Drug metabolism and disposition: the biological fate of chemicals.

Inhibition of O6-alkylguanine-DNA alkyltransferase by O6-benzyl-N 2-acetylguanosine increases chloroethylnitrosourea-induced apoptosis in Mer+ human melanoma cells

J. Madelmont, C. Marchenay, C. Rolhion, 2002, Melanoma research.

Inhibition of O-alkylguanine-DNA alkyltransferase by O-benzyl-N2-acetylguanosine increases chloroethylnitrosourea-induced apoptosis in Mer human melanoma cells

C. Marchenay, C. Rolhion, E. Débiton, 2002 .

Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene

Y. Bignon, J. Maurizis, P. Rio, 1999, International journal of cancer.

Presence of reverse transcriptase in human leukemias and lymphomas.

P. Chollet, J. Chassagne, J. Maurizis, 1990, Clinica chimica acta; international journal of clinical chemistry.

Disposition in rat of a new fluorinated, biocompatible, non-ionic telomeric carrier.

A. Veyre, J. Madelmont, B. Pucci, 1994, Xenobiotica; the fate of foreign compounds in biological systems.

Presence of HLA-D/DR antigens on the membrane of breast tumour cells.

M. D. De Latour, P. Chollet, J. Chassagne, 1984, Clinical and experimental immunology.

Enhancement by O6-benzyl-N2-acetylguanosine of N'-[2-chloroethyl]-N-[2-(methylsulphonyl)ethyl]-N'-nitrosourea therapeutic index on nude mice bearing resistant human melanoma.

A. Veyre, J. Madelmont, E. Débiton, 1997, British Journal of Cancer.

Synthesis of three no-carrier-added O6-4-[125I] iodobenzylguanosine derivatives, new reagents for the assay of O6-alkylguanine-DNA alkyltransferase activity

A. Veyre, J. Madelmont, M. Moreau, 1995 .

Synthesis of all-trans-beta-carotene retinoids and derivatives labelled with 14C

A. Veyre, J. Madelmont, P. Grolier, 1996 .

Disposition in rats and mice of 7-methoxy-2-nitronaphtho[2,1-b]furan.

J. Buisson, J. Madelmont, J. Maurizis, 1985, Xenobiotica; the fate of foreign compounds in biological systems.

Isolation, purification and quantification of BRCA1 protein from tumour cells by affinity perfusion chromatography.

Y. Bignon, J. Chassagne, C. Hızel, 1999, Journal of chromatography. B, Biomedical sciences and applications.

Synthesis of N-quaternary ammonium [3H] and [99mTc]polyazamacrocycles, potential radiotracers for cartilage imaging

J. Madelmont, J. Maurizis, M. Borel, 2000 .

In vitro and in vivo evaluations of THAM derived telomers bearing RGD and Ara-C for tumour neovasculature targeting.

B. Pucci, J. Maurizis, M. Rapp, 2003, European journal of medicinal chemistry.

Application to a cartilage targeting strategy: synthesis and in vivo biodistribution of (14)C-labeled quaternary ammonium-glucosamine conjugates.

J. Madelmont, I. Giraud, J. Maurizis, 2000, Bioconjugate chemistry.

A new class of sulfoxide surfactants derived from Tris. Synthesis and preliminary assessments of their properties.

P. Barthélémy, B. Pucci, J. Lacombe, 1998, Bioorganic & medicinal chemistry letters.

Stressed Jerusalem artichoke tubers (Helianthus tuberosus L.) excrete a protein fraction with specific cytotoxicity on plant and animal tumour cell.

J. Madelmont, E. Débiton, G. Ledoigt, 2007, Biochimica et biophysica acta.

Disposition and metabolism of acetylcholinesterase reactivators 2PAM-I, TMB4 and R665 in rats submitted to organophosphate poisoning.

A. Veyre, J. Madelmont, A. Louvel, 1991, Xenobiotica; the fate of foreign compounds in biological systems.

Synthesis and pharmacokinetic profile of a quaternary ammonium derivative of chlorambucil, a potential anticancer drug for the chemotherapy of chondrosarcoma.

J. Madelmont, I. Giraud, J. Maurizis, 2003, Bioorganic & medicinal chemistry.

Tissue distribution and metabolism in rat of an ethynesulphonamide with filaricidal activity.

A. Veyre, J. Madelmont, P. Gayral, 1997, Xenobiotica; the fate of foreign compounds in biological systems.

Cross‐reaction between antibodies raised against the last 20 C‐terminal amino acids of BRCA 1 (C‐20) and human EGF and EGF‐R in MCF 10a human mammary epithelial cell line

Y. Bignon, J. Maurizis, D. Bernard-Gallon, 1997, International journal of cancer.

Thyroid hormone synthesis and reactivity of hormone‐forming tyrosine residues of thyroglobulin

S. Lissitzky, C. Marriq, J. Maurizis, 1981, FEBS letters.

Mechanism of an in vitro biosynthesis of thyroid hormones from 3,5-diiodo-l-tyrosyl-3,5-diiodo-l-tyrosine: I. Manifestation of the elimination of the alanine side chain of the N-terminal diiodotyrosine

J. Michelot, J. Maurizis, G. Meyniel, 1978 .

Mechanism of an in vitro biosynthesis of thyroid hormones from 3,5-diiodo-l-tyrosyl-3,5-diiodo-l-tyrosine: II. Role of the pyridoxal phosphate and of the peroxidase

J. Michelot, J. Maurizis, G. Meyniel, 1978 .

Effect of prolactin on class II HLA antigen expression by MCF7 cell line.

P. Chollet, J. Chassagne, J. Maurizis, 1986, Anticancer Research.

Thyroid peroxidase‐induced thyroid hormone synthesis in relation to thyroglobulin structure

S. Lissitzky, C. Marriq, J. Maurizis, 1979, FEBS letters.